AP616A - Treatment of post-herpetic neuralgia with antiviral guanine derivatives. - Google Patents

Treatment of post-herpetic neuralgia with antiviral guanine derivatives. Download PDF

Info

Publication number
AP616A
AP616A APAP/P/1994/000684A AP9400684A AP616A AP 616 A AP616 A AP 616A AP 9400684 A AP9400684 A AP 9400684A AP 616 A AP616 A AP 616A
Authority
AP
ARIPO
Prior art keywords
famciclovir
treatment
patients
placebo
pain
Prior art date
Application number
APAP/P/1994/000684A
Other languages
English (en)
Other versions
AP9400684A0 (en
Inventor
Ronald James Boon
David Ronald John Griffin
Original Assignee
Novartis Int Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26303637&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP616(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB939320485A external-priority patent/GB9320485D0/en
Priority claimed from GB939321255A external-priority patent/GB9321255D0/en
Application filed by Novartis Int Pharmaceutical Ltd filed Critical Novartis Int Pharmaceutical Ltd
Publication of AP9400684A0 publication Critical patent/AP9400684A0/xx
Application granted granted Critical
Publication of AP616A publication Critical patent/AP616A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
APAP/P/1994/000684A 1993-10-05 1994-10-05 Treatment of post-herpetic neuralgia with antiviral guanine derivatives. AP616A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939320485A GB9320485D0 (en) 1993-10-05 1993-10-05 Pharmaceuticals
GB939321255A GB9321255D0 (en) 1993-10-14 1993-10-14 Pharmaceuticals

Publications (2)

Publication Number Publication Date
AP9400684A0 AP9400684A0 (en) 1994-10-31
AP616A true AP616A (en) 1997-09-15

Family

ID=26303637

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1994/000684A AP616A (en) 1993-10-05 1994-10-05 Treatment of post-herpetic neuralgia with antiviral guanine derivatives.

Country Status (17)

Country Link
US (1) US5866581A (ja)
EP (1) EP0804199B1 (ja)
JP (1) JP3768527B2 (ja)
CN (1) CN1082816C (ja)
AP (1) AP616A (ja)
AT (1) ATE216885T1 (ja)
AU (1) AU7788494A (ja)
CA (1) CA2173505C (ja)
CY (1) CY2375B1 (ja)
DE (1) DE69430545T2 (ja)
DK (1) DK0804199T3 (ja)
ES (1) ES2176258T3 (ja)
HK (1) HK1004115A1 (ja)
HU (1) HU226472B1 (ja)
IL (1) IL111138A (ja)
PT (1) PT804199E (ja)
WO (1) WO1995009632A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9600847D0 (en) 1996-01-16 1996-03-20 Smithkline Beecham Plc Pharmaceuticals
SI1093366T1 (en) * 1998-07-09 2005-02-28 Warner-Lambert Company Llc Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles
US6419934B1 (en) 1999-02-24 2002-07-16 Edward L. Tobinick TNF modulators for treating neurological disorders associated with viral infection
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
AU2013257951A1 (en) * 2012-05-11 2015-01-22 Akron Molecules Ag Use of compounds for the treatment of pain

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141927A2 (en) * 1983-08-18 1985-05-22 Beecham Group Plc Antiviral guanine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0182024B1 (en) * 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141927A2 (en) * 1983-08-18 1985-05-22 Beecham Group Plc Antiviral guanine derivatives

Also Published As

Publication number Publication date
JPH10513434A (ja) 1998-12-22
CA2173505A1 (en) 1995-04-13
AP9400684A0 (en) 1994-10-31
PT804199E (pt) 2002-09-30
DE69430545T2 (de) 2002-11-07
CA2173505C (en) 2005-03-29
JP3768527B2 (ja) 2006-04-19
CN1082816C (zh) 2002-04-17
WO1995009632A1 (en) 1995-04-13
DK0804199T3 (da) 2002-08-19
CN1135180A (zh) 1996-11-06
EP0804199A1 (en) 1997-11-05
AU7788494A (en) 1995-05-01
CY2375B1 (en) 2004-06-04
ATE216885T1 (de) 2002-05-15
IL111138A0 (en) 1994-12-29
HK1004115A1 (en) 1998-11-20
HU226472B1 (en) 2008-12-29
ES2176258T3 (es) 2002-12-01
EP0804199B1 (en) 2002-05-02
IL111138A (en) 1997-04-15
HU9600882D0 (en) 1996-05-28
HUT74076A (en) 1996-10-28
DE69430545D1 (de) 2002-06-06
US5866581A (en) 1999-02-02

Similar Documents

Publication Publication Date Title
CA3188794A1 (en) Methods of treating coronavirus infections by co-administering an fkbp ligand and an antiviral agent
AP616A (en) Treatment of post-herpetic neuralgia with antiviral guanine derivatives.
Goodman et al. Prospective double-blind evaluation of topical adenine arabinoside in male herpes progenitalis
US6124304A (en) Penciclovir for the treatment of zoster associated pain
US4093716A (en) Compositions containing 5-amino-5-deoxythymidine and pharmaceutically acceptable salts thereof
Whitley et al. Herpes zoster: focus on treatment in older adults
AU696833B2 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
Nikkels et al. Current treatments of muco-cutaneous herpes simplex virus infections
EP1865961B1 (en) Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
KR101876019B1 (ko) 엔-메탄노카르바티미딘을 이용한 대상포진의 치료방법
de Bony et al. Lack of interaction between valaciclovir, the L-valyl ester of acyclovir, and Maalox antacid
EP0723448A1 (en) Use of peniclorin for the treatment of posttherapeutic neuralgia
WO1995017190A1 (en) Pharmaceuticals
US20120329815A1 (en) Famciclovir for the Treatment of Recurrent Herpes Labialis using a One-Day Treatment
EP2394651A1 (en) Penciclovir or Famciclovir for the Treatment of Recurrent Genital Herpes With a One-Day Application